|
|
| Line 34: |
Line 34: |
| == MMP12 == | | == MMP12 == |
|
| |
|
| [[3lka]] - hMMP12 catalytic domain+hydroxamic acid+paramethoxy-sulfonyl amide – human<br /> | | [[Matrix metalloproteinase]] |
| [[3ba0]], [[1jk3]] – hMMP12<br />
| |
| [[3ehx]], [[3ehy]], [[1utt]], [[1utz]], [[1ros]] - hMMP12 catalytic domain+inhibitor<br />
| |
| [[2oxu]] - hMMP12 catalytic domain<br />
| |
| [[2oxw]], [[2oxz]] - hMMP12 catalytic domain+peptide<br />
| |
| [[2hu6]] - hMMP12 catalytic domain+bicyclic inhibitor<br />
| |
| [[1rmz]] - hMMP12 catalytic domain+ inhibitor NNGH<br />
| |
| [[1y93]] - hMMP12 catalytic domain+acetohydroxamic acid<br />
| |
| [[1jiz]] – hMMP12+ hydroxamic acid<br />
| |
| [[1os2]] - hMMP12 (mutant)+hydroxamic acid<br />
| |
| [[1os9]] - hMMP12 (mutant)<br />
| |
| [[3f15]], [[3f16]], [[3f17]], [[3f18]], [[3f19]], [[3f1a]], [[3n2u]], [[3n2v]], [[3nx7]] - hMMP12 catalytic domain+sulfonamide inhibitor<br />
| |
| [[2w0d]] - hMMP12 catalytic domain (mutant)<br />
| |
| [[2krj]], [[2k9c]] – hMMP12 fraction – NMR<br />
| |
| [[2jxy]] - hMMP12 hemopexin-like domain – NMR<br />
| |
| [[2k2g]] - hMMP12 catalytic domain+inhibitor – NMR<br />
| |
| [[2poj]] - hMMP12 catalytic domain – NMR<br />
| |
| [[2z2d]] - hMMP12 catalytic domain+butanoic acid – NMR<br />
| |
| [[1ycm]], [[1z3j]] – hMMP12 (mutant)+hydroxamic acid derivative - NMR<br />
| |
| [[3lk8]] - hMMP12 catalytic domain (mutant)+hydroxamic acid derivative<br />
| |
| [[2wo8]], [[2wo9]], [[2woa]] – hMMP12 fraction+hydroxy carboxylic acid<br />
| |
| [[3lik]], [[3lil]], [[3lir]], [[3ljg]] – hMMP12 catalytic domain (mutant)+chelating inhibitor
| |
|
| |
|
| == MMP16 == | | == MMP16 == |
|
| |
|
| [[1rm8]] – hMMP16+batimastat | | [[Matrix metalloproteinase]] |
|
| |
|
| == ELA == | | == ELA == |
